Jf. Burris et al., THE EFFECT OF AMLODIPINE ON AMBULATORY BLOOD-PRESSURE IN HYPERTENSIVEPATIENTS, The American journal of cardiology, 73(3), 1994, pp. 10000039-10000043
Certain high-risk populations, such as diabetics and blacks, have sust
ained elevation in blood pressure and heart rate throughout the day an
d night, with blunting of the usual diurnal variability pattern. This
may contribute to their higher incidence of left ventricular hypertrop
hy (blacks) and cardiovascular complications (diabetics). Hypertensive
s who maintain a diurnal pattern of blood pressure variation still exh
ibit higher daytime and nocturnal blood pressure levels than normotens
ives. Thus, to achieve maximum effectiveness in treating hypertension,
24-hour control of blood pressure is necessary. Antihypertensive agen
ts should effectively reduce blood pressure consistently throughout a
24-hour period. The objective of this study was to assess the effects
of amlodipine, 5 mg once daily, on blood pressure measured by 24-hour
ambulatory monitoring in a randomized, double-blind, placebo-controlle
d single-site study. Patients with mild to-moderate essential hyperten
sion were randomized to receive amlodipine (n = 11) or placebo (n = 5)
in a 2:1 ratio. A 4-week single-blind placebo run-in period was follo
wed by a 4-week double-blind phase. Ambulatory monitoring of blood pre
ssure was carried out for 24 hours at the end of each 4-week phase. Pa
tients receiving amlodipine had significantly lower blood pressure com
pared with placebo 24 hours after the last dose (supine blood pressure
-25.1/-10.1 mm Hg; standing blood pressure -21.2/-9.7 mm Hg) after 4
weeks of treatment. This effect was clearly demonstrated by the 24-hou
r postdose measurement and the mean blood pressure over the 24-hour in
terval as measured by ambulatory recordings. The mean hourly ambulator
y recordings showed that amlodipine maintained both diastolic and syst
olic pressures below tbe base line levels at every hour during the 24-
hour observation period. Nine of 10 evaluable patients (90%) on amlodi
pine responded vs only 1 of 5 patients (20%) on placebo. The decrease
in blood pressure for the amlodipine patients was not accompanied by a
significant increase in pulse rate. Amlodipine was well tolerated; po
ssibly drug-related side effects of intermittent headache and nocturia
were experienced by 1 patient each; the latter had been present durin
g the placebo run-in phase. Amlodipine is effective, well tolerated, a
nd may be administered once daily for effective 24-hour blood pressure
control.